61 related articles for article (PubMed ID: 23098063)
1. Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer.
Sheikhshabani SH; Modarres P; Ghafouri-Fard S; Amini-Farsani Z; Khodaee L; Shaygan N; Amini-Farsani Z; Omrani MD
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1970. PubMed ID: 38351531
[TBL] [Abstract][Full Text] [Related]
2. Platinum-based targeted chemotherapies and reversal of cisplatin resistance in non-small cell lung cancer (NSCLC).
Umar H; Wahab HA; Attiq A; Amjad MW; Bukhari SNA; Ahmad W
Mutat Res; 2024; 828():111856. PubMed ID: 38520879
[TBL] [Abstract][Full Text] [Related]
3. Silencing of TMEM158 Inhibits Tumorigenesis and Multidrug Resistance in Colorectal Cancer.
Liu L; Zhang J; Li S; Yin L; Tai J
Nutr Cancer; 2020; 72(4):662-671. PubMed ID: 31389251
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TMEM158 contributes to ovarian carcinogenesis.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
J Exp Clin Cancer Res; 2015 Aug; 34(1):75. PubMed ID: 26239324
[TBL] [Abstract][Full Text] [Related]
5. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate genes associated with triple negative breast cancer.
Player A; Abraham N; Burrell K; Bengone IO; Harris A; Nunez L; Willaims T; Kwende S; Walls W
Genes Cancer; 2017 Jul; 8(7-8):659-672. PubMed ID: 28966727
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic transmembrane protein 158 drives the PI3K/Akt signaling pathway to accelerate gastric cancer cell growth.
Cui X; Lu J; Zhao C; Duan Y
Braz J Med Biol Res; 2023; 56():e12943. PubMed ID: 37970923
[TBL] [Abstract][Full Text] [Related]
8. The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer.
Herrera-Quiterio GA; Encarnación-Guevara S
Front Oncol; 2023; 13():1244740. PubMed ID: 37936608
[TBL] [Abstract][Full Text] [Related]
9. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
[TBL] [Abstract][Full Text] [Related]
10. TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers.
Huang J; Liu W; Zhang D; Lin B; Li B
Front Oncol; 2022; 12():1023455. PubMed ID: 36387246
[TBL] [Abstract][Full Text] [Related]
11. TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-β to Mediate EMT in Triple-Negative Breast Cancer.
Tong J; Li H; Hu Y; Zhao Z; Li M
J Cancer; 2022; 13(8):2694-2704. PubMed ID: 35711843
[TBL] [Abstract][Full Text] [Related]
12. TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas.
Li J; Wang X; Chen L; Zhang J; Zhang Y; Ren X; Sun J; Fan X; Fan J; Li T; Tong L; Yi L; Chen L; Liu J; Shang G; Ren X; Zhang H; Yu S; Ming H; Huang Q; Dong J; Zhang C; Yang X
Cancer Gene Ther; 2022 Aug; 29(8-9):1117-1129. PubMed ID: 34992215
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-548ac induces apoptosis in laryngeal squamous cell carcinoma cells by targeting transmembrane protein 158.
Song F; Yang Y; Liu J
Oncol Lett; 2020 Oct; 20(4):69. PubMed ID: 32863902
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide identification of key modulators of gene-gene interaction networks in breast cancer.
Chiu YC; Wang LJ; Hsiao TH; Chuang EY; Chen Y
BMC Genomics; 2017 Oct; 18(Suppl 6):679. PubMed ID: 28984209
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity.
Lu J; Zhang X; Shen T; Ma C; Wu J; Kong H; Tian J; Shao Z; Zhao X; Xu L
Evid Based Complement Alternat Med; 2016; 2016():7276161. PubMed ID: 27087825
[TBL] [Abstract][Full Text] [Related]
16. DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines.
Salim H; Zong D; Hååg P; Novak M; Mörk B; Lewensohn R; Lundholm L; Viktorsson K
BMC Cancer; 2015 Sep; 15():628. PubMed ID: 26353782
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations.
Lopez-Ayllon BD; Moncho-Amor V; Abarrategi A; Ibañez de Cáceres I; Castro-Carpeño J; Belda-Iniesta C; Perona R; Sastre L
Cancer Med; 2014 Oct; 3(5):1099-111. PubMed ID: 24961511
[TBL] [Abstract][Full Text] [Related]
18. TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells.
Mohammed Ael S; Eguchi H; Wada S; Koyama N; Shimizu M; Otani K; Ohtaki M; Tanimoto K; Hiyama K; Gaber MS; Nishiyama M
Exp Lung Res; 2012 Nov; 38(9-10):463-74. PubMed ID: 23098063
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
